243 related articles for article (PubMed ID: 15234279)
1. Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model.
Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
Am J Ophthalmol; 2004 Jul; 138(1):33-7. PubMed ID: 15234279
[TBL] [Abstract][Full Text] [Related]
2. Intracameral Vigamox (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model.
Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
Am J Ophthalmol; 2005 Sep; 140(3):497-504. PubMed ID: 16083841
[TBL] [Abstract][Full Text] [Related]
3. Prevention of endophthalmitis by collagen shields presoaked in fourth-generation fluoroquinolones versus by topical prophylaxis.
Haugen B; Werner L; Romaniv N; Haymore J; Kleinmann G; Mamalis N; Olson RJ
J Cataract Refract Surg; 2008 May; 34(5):853-8. PubMed ID: 18471646
[TBL] [Abstract][Full Text] [Related]
4. Effects of intravitreal moxifloxacin and dexamethasone in experimental Staphylococcus aureus endophthalmitis.
Ermis SS; Cetinkaya Z; Kiyici H; Inan UU; Ozturk F
Curr Eye Res; 2007 Apr; 32(4):337-44. PubMed ID: 17453955
[TBL] [Abstract][Full Text] [Related]
5. Topical 0.5% moxifloxacin prevents endophthalmitis in an intravitreal injection rabbit model.
Kowalski RP; Romanowski EG; Mah FS; Yates KA; Gordon YJ
J Ocul Pharmacol Ther; 2008 Feb; 24(1):1-7. PubMed ID: 18370872
[TBL] [Abstract][Full Text] [Related]
6. A comparison of moxifloxacin and levofloxacin topical prophylaxis in a fluoroquinolone-resistant Staphylococcus aureus rabbit model.
Kowalski RP; Romanowski EG; Mah FS; Sasaki H; Fukuda M; Gordon YJ
Jpn J Ophthalmol; 2008; 52(3):211-216. PubMed ID: 18661272
[TBL] [Abstract][Full Text] [Related]
7. The effect of cataract surgery on ocular levels of topical moxifloxacin.
Mather R; Stewart JM; Prabriputaloong T; Wong J; McLeod SD
Am J Ophthalmol; 2004 Oct; 138(4):554-9. PubMed ID: 15488780
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the safety of prophylactic intracameral moxifloxacin in cataract surgery.
Lane SS; Osher RH; Masket S; Belani S
J Cataract Refract Surg; 2008 Sep; 34(9):1451-9. PubMed ID: 18721703
[TBL] [Abstract][Full Text] [Related]
9. Prophylactic effect of intravenous moxifloxacin in a rabbit model of Staphylococcus epidermidis endophthalmitis.
Kim JY; Kim SY
Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1742-7. PubMed ID: 21169530
[TBL] [Abstract][Full Text] [Related]
10. Experimental intracameral injection of vancomycin microparticles in rabbits.
Kodjikian L; Couprie J; Hachicha W; Timour Q; Devouassoux M; Builles N; Hartmann D; Fessi H
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4125-32. PubMed ID: 20335605
[TBL] [Abstract][Full Text] [Related]
11. Perspectives on antibiotics for postoperative endophthalmitis prophylaxis: potential role of moxifloxacin.
O'Brien TP; Arshinoff SA; Mah FS
J Cataract Refract Surg; 2007 Oct; 33(10):1790-800. PubMed ID: 17889778
[TBL] [Abstract][Full Text] [Related]
12. The comparison of fluoroquinolones to nonfluoroquinolone antibacterial agents for the prevention of endophthalmitis in a rabbit model.
Kowalski RP; Romanowski EG; Shanks RM; Mah FS
J Ocul Pharmacol Ther; 2012 Dec; 28(6):604-8. PubMed ID: 22925112
[TBL] [Abstract][Full Text] [Related]
13. Intracameral Vigamox (moxifloxacin 0.5%) is not effective in preventing endophthalmitis in a rabbit model.
Kodjikian L; Garweg JG
Am J Ophthalmol; 2006 Apr; 141(4):777; author reply 777-8. PubMed ID: 16564833
[No Abstract] [Full Text] [Related]
14. Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model.
Oguz H; Ozbilge H; Oguz E; Gurkan T
Curr Eye Res; 2005 Mar; 30(3):155-61. PubMed ID: 15804740
[TBL] [Abstract][Full Text] [Related]
15. Comparison of 2 moxifloxacin regimens for preoperative prophylaxis: prospective randomized triple-masked trial. Part 1: aqueous concentration of moxifloxacin.
Vasavada AR; Gajjar D; Raj SM; Vasavada V; Vasavada V
J Cataract Refract Surg; 2008 Aug; 34(8):1379-82. PubMed ID: 18655991
[TBL] [Abstract][Full Text] [Related]
16. Prevention of Staphylococcus aureus endophthalmitis with topical gatifloxacin in a rabbit prophylaxis model.
de Castro LE; Sandoval HP; Bartholomew LR; Vroman DT; Solomon KD
J Ocul Pharmacol Ther; 2006 Apr; 22(2):132-8. PubMed ID: 16722799
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of besifloxacin in a rabbit model of methicillin-resistant Staphylococcus aureus keratitis.
Sanders ME; Norcross EW; Moore QC; Shafiee A; Marquart ME
Cornea; 2009 Oct; 28(9):1055-60. PubMed ID: 19724203
[TBL] [Abstract][Full Text] [Related]
18. Anterior chamber irrigation with an ozonated solution as prophylaxis against infectious endophthalmitis.
Takahashi H; Fujimoto C; Matsui H; Igarashi T; Shiwa T; Ohara K; Sugita T
J Cataract Refract Surg; 2004 Aug; 30(8):1773-80. PubMed ID: 15313306
[TBL] [Abstract][Full Text] [Related]
19. Penetration of second-, third-, and fourth-generation topical fluoroquinolone into aqueous and vitreous humour in a rabbit endophthalmitis model.
Yağci R; Oflu Y; Dinçel A; Kaya E; Yağci S; Bayar B; Duman S; Bozkurt A
Eye (Lond); 2007 Jul; 21(7):990-4. PubMed ID: 16732216
[TBL] [Abstract][Full Text] [Related]
20. A highly virulent Staphylococcus aureus: rabbit anterior chamber infection, characterization, and genetic analysis.
Balzli CL; Bartell J; Dajcs JJ; McCormick CC; Caballero AR; Stroman D; O'Callaghan RJ
Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):5114-20. PubMed ID: 20463315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]